Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

10 avr. 2015 08h30 HE | Source: Arbutus Biopharma Corporation

FDA Modifies Partial Clinical Hold on Tekmira's TKM-Ebola IND to Allow Multiple Dosing of Healthy Volunteers

VANCOUVER, British Columbia, April 10, 2015 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR), an industry-leading therapeutic solutions company focused on developing a cure for...
10 avr. 2015 08h00 HE | Source: CombiMatrix Corporation

New England Journal of Medicine Article Supports Importance of Follow-up Diagnostic Testing Following Positive Noninvasive Prenatal Screening Test

IRVINE, Calif., April 10, 2015 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based diagnostic services for prenatal, postnatal, and...
09 avr. 2015 10h12 HE | Source: Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals' HPV Immunotherapy Recognized as "Best Therapeutic Vaccine" by World Vaccine Congress

PLYMOUTH MEETING, Pa., April 9, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) today announced that it was recognized with a prestigious industry award at the World Vaccine...
09 avr. 2015 09h00 HE | Source: GeoVax Labs, Inc.

GeoVax Provides Details of Presentation at World Vaccine Congress

ATLANTA, GA--(Marketwired - Apr 9, 2015) - GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing innovative human vaccines for Ebola and HIV using its novel platform technology, today...
09 avr. 2015 08h00 HE | Source: Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals HPV Immunotherapy Activates Robust In Vivo T Cell Responses in Head & Neck Cancer Patients

PLYMOUTH MEETING, Pa., April 9, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today preliminary data showing that its INO-3112 DNA-based immunotherapy generated...
08 avr. 2015 16h15 HE | Source: TRACON Pharmaceuticals, Inc.

TRACON Pharmaceuticals Expands License Agreement and Signs Research Agreement With Case Western Reserve University

SAN DIEGO, April 8, 2015 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
08 avr. 2015 16h05 HE | Source: CareDx, Inc.

CareDx to Present New Data on AlloMap(R) and Cell-Free DNA (cfDNA) Biomarker in Heart Transplant Recipients at ISHLT 2015

BRISBANE, Calif., April 8, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
08 avr. 2015 09h00 HE | Source: Ancestry, Inc.

Ancestry.com LLC to Announce First Quarter 2015 Financial Results

PROVO, Utah, April 8, 2015 (GLOBE NEWSWIRE) -- Ancestry.com LLC, the world's largest online family history resource, will release financial results for its first quarter 2015 on Wednesday, April 22,...
08 avr. 2015 06h00 HE | Source: MediaValet, Inc.;Sawgrass Technologies

Sawgrass Selects MediaValet to Make Digital Assets Globally Available

CHARLESTON, SC and VANCOUVER, BC--(Marketwired - April 08, 2015) - Sawgrass, the industry leader in dye sublimation and digital ink technologies, has selected MediaValet (TSX VENTURE: MVP) to help...
08 avr. 2015 06h00 HE | Source: Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals Selected by DARPA to Lead a $45 Million Program to Expedite Development of Novel Products to Prevent and Treat Disease Caused by Ebola

PLYMOUTH MEETING, Pa., April 8, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that the company has been selected to receive a grant from the Defense Advanced...

Page précédente

Page suivante